Risk Factor Analysis for 30-day Mortality After Surgery for Infective Endocarditis

Abstract

Background Infective endocarditis (IE) remains a challenging disease associated with high mortality. Several scores have been suggested to assess surgical risk. None was sufficiently adequate. We therefore analyzed risk factors for 30-day mortality.

Methods A total of 438 consecutive patients had surgery for IE in our department between 2002 and 2020. Patients were divided into two groups, one consisting of 30-day survivors (362 patients; 82.6%) and one of nonsurvivors (76 patients; 17.4%). Logistic regression analysis on pre- and intraoperative risk factors was performed and the groups were compared by univariable analyses.

Results Patients in mortality group were older (69 [58, 77] vs. 63 [50, 72] years; p < 0.001), EuroSCORE II was higher (24.5 [12.1, 49.0] vs. 8.95 [3.7, 21.2]; p < 0.001) and there were more females. More frequently left ventricular function (below 30%), preoperative acute renal insufficiency, chronic dialysis, insulin-dependent diabetes mellitus, NYHA-class IV (New York Heart Association heart failure class IV), and cardiogenic shock occurred. Patients in the mortality group were often intensive care unit patients (40.8 vs. 22.4%; p < 0.001) or had a preoperative stroke (26.3 vs. 16.0%; p = 0.033). In the nonsurvivor group Staphylococcus aureus was prevalent. Streptococcus viridans was common in the survivor group as was isolated aortic valve endocarditis (32.9 vs. 17.1%; p = 0.006). Prosthetic valve endocarditis (PVE) and abscesses occurred more often in nonsurvivors. In the logistic regression analysis, female gender, chronic dialysis, cardiogenic shock, and NYHA IV and from intraoperative variables PVE, cardiopulmonary bypass time, and mitral valve surgery were the strongest predictors for 30-day mortality.

Conclusion This study indeed clearly indicates that significant risk factors for 30-day mortality cannot be changed. Nevertheless, they should be taken into account for preoperative counselling, and they will alert the surgical team for an even more careful management.

Keywords

endocarditis - heart valve surgery - infection - outcomes (mortality morbidity)

Authors' Contribution

J.J.M. and C.F. shared the responsibility for conceptualization, methodology, validation, investigation, and project administration. J.J.M. was more responsible for data curation, whereas C.F. was mainly in charge of the formal analysis. They both wrote the original draft and did the review and editing.

^* These authors share Equal authorship.

Publication History

Received: 07 September 2023

Accepted: 01 December 2023

Article published online:
19 February 2024

• References

• 1 Lalanne S, Cattoir V, Guerin F, Verdier MC, Revest M. Differential response to antibiotic therapy in staphylococcal infective endocarditis: contribution of an ex vivo model. J Antimicrob Chemother 2023; 78 (07) 1689-1693
• 2 Chu VH, Park LP, Athan E. et al; International Collaboration on Endocarditis (ICE) Investigators*. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation 2015; 131 (02) 131-140
• 3 Fernández-Cisneros A, Hernández-Meneses M, Llopis J. et al; Equip d'Endocarditis de l'Hospital Clínic de Barcelona. Risk scores' performance and their impact on operative decision-making in left-sided endocarditis: a cohort study. Eur J Clin Microbiol Infect Dis 2023; 42 (01) 33-42
• 4 Gaca JG, Sheng S, Daneshmand MA. et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg 2011; 141 (01) 98-106 .e1, 2
• 5 Scheggi V, Menale S, Tonietti B. et al. Impact of septic cerebral embolism on prognosis and therapeutic strategies of infective endocarditis: a retrospective study in a surgical centre. BMC Infect Dis 2022; 22 (01) 554
• 6 Durante-Mangoni E, Bradley S, Selton-Suty C. et al; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008; 168 (19) 2095-2103
• 7 Albes JM. Current practice in prophylaxis of endocarditis: are we running into trouble?. Eur J Cardiothorac Surg 2019; 56 (01) 1-6
• 8 Friedrich C, Salem M, Puehler T. et al. Sex-specific risk factors for short- and long-term outcomes after surgery in patients with infective endocarditis. J Clin Med 2022; 11 (07) 1875
• 9 Tu JV, Jaglal SB, Naylor CD. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery. Circulation 1995; 91 (03) 677-684
• 10 Patrat-Delon S, Rouxel A, Gacouin A. et al. EuroSCORE II underestimates mortality after cardiac surgery for infective endocarditis. Eur J Cardiothorac Surg 2016; 49 (03) 944-951
• 11 Gatti G, Perrotti A, Obadia JF. et al; Association for the Study and Prevention of Infective Endocarditis Study Group–Association pour l'Étude et la Prévention de l'Endocadite Infectieuse (AEPEI). Simple scoring system to predict in-hospital mortality after surgery for infective endocarditis. J Am Heart Assoc 2017; 6 (07) e004806
• 12 Imaizumi T, Fujii N, Hamano T. et al; CRIC Study Investigators. Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function. Kidney Int 2023; 103 (05) 949-961
• 13 Pacholewicz J, Kuligowska E, Szylińska A. et al. The rate of postoperative mortality and renal and respiratory complications are increased in patients with extreme obesity undergoing cardiac surgery - a retrospective observational cohort study of 8848 patients. Diabetes Metab Syndr Obes 2023; 16: 1155-1166
• 14 Nishimura RA, Otto CM, Bonow RO. et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 2017; 135 (25) e1159-e1195
• 15 The 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J 2015; 36 (44) 3036-3037
• 16 Anantha Narayanan M, Mahfood Haddad T, Kalil AC. et al. Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis. Heart 2016; 102 (12) 950-957
• 17 Lauridsen TK, Park L, Tong SY. et al. Echocardiographic findings predict in-hospital and 1-year mortality in left-sided native valve Staphylococcus aureus endocarditis: analysis from the international collaboration on endocarditis-prospective echo cohort study. Circ Cardiovasc Imaging 2015; 8 (07) e003397
• 18 Fowler Jr VG, Das AF, Lipka-Diamond J. et al. Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis. J Clin Invest 2020; 130 (07) 3750-3760
• 19 Kim HJ, Kim JE, Lee JY, Lee SH, Jung JS, Son HS. Perioperative red blood cell transfusion is associated with adverse cardiovascular outcomes in heart valve surgery. Anesth Analg 2023; 137 (01) 153-161
• 20 Kwak SH, Ahn S, Shin MH. et al. Identification of biomarkers for the diagnosis of sepsis-associated acute kidney injury and prediction of renal recovery in the intensive care unit. Yonsei Med J 2023; 64 (03) 181-190
• 21 Ostovar R, Schroeter F, Erb M, Kuehnel RU, Hartrumpf M, Albes JM. Endocarditis: who is particularly at risk and why? Ten years analysis of risk factors for in-hospital mortality in infective endocarditis. Thorac Cardiovasc Surg 2023; 71 (01) 12-21